Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of 24 Months of Teriparatide Therapy on Bone Microarchitecture and Bone Volume in Men and Women With Osteoporosis

NCT01155232 is registered in ClinicalTrials.gov with University Health Network, Toronto as lead sponsor.

NCT NCT01155232
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01155232 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of 24 Months of Teriparatide Therapy on Bone Microarchitecture and Bone Volume in Men and Women With Osteoporosis
Lead sponsor
University Health Network, Toronto
Phase
Observational
Overall status
Active, not recruiting
Start date
November 30, 2004
Completion date
January 31, 2028
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

osteoporosis